in ,

Dis-Chem Stake of South Africa’s Saltzman Billionaires Surges, Adding $21 Million

The Saltzman family, well-known South African billionaires and founders of Dis-Chem Pharmacies (Dis-Chem), have seen a significant increase in the market value of their stake in the retail pharmacy chain and healthcare organization. This is due to the recent increase in the group’s shares on the Johannesburg Stock Exchange (JSE).

Over the last 19 days, the market value of the Saltzman family’s holding in Dis-Chem has climbed by R398.73 million ($21.08 million), driven by renewed investor interest in the company.

Dis-Chem Pharmacies, a leading South African retail pharmacy and healthcare firm, has established itself as a dominant force in the healthcare market since its inception more than four decades ago by Lynette and Ivan Saltzman. The firm provides a diverse range of services, including dispensaries, family clinics, wound care clinics, and full self-medication centers.

Lynette and Ivan Saltzman own a sizable 35.12 percent share in the Gauteng-based healthcare firm. Under their leadership, the company has expanded into one of Africa’s largest retail pharmacy chains, with over 300 locations and more than 20,000 employees.

Dis-Chem Pharmacies’ shares on the JSE have risen by 4.15 percent in the last 19 days. The share price increased from R31.79 ($1.6808) on March 6 to R33.11 ($1.7505). This has boosted the group’s market valuation above $1.5 billion, resulting in significant benefits for shareholders.

The Saltzman family’s shareholding in Dis-Chem Pharmacies has increased by R398.73 million ($21.08 million), from R9.60 billion ($507.60 million) to R10 billion ($528.68 million) as of this report.

The Saltzman family’s share in Dis-Chem has increased in market value by $21.08 million, cementing their position as key investors on the JSE and reinforcing their sustained influence in South Africa’s healthcare and pharmacy retail arena.

Leave a Reply

Your email address will not be published. Required fields are marked *

South African Mogul Laurie Dippenaar’s FirstRand Stock Loss Amounts to $17.2 Million

Jonathan Jawno’s Transaction Capital Offloads Nutun’s Australian Unit